FYNALE

This brand name is authorized in Nigeria.

Active ingredients

The drug FYNALE contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether
2	Lumefantrine UNII F38R0JR742 - LUMEFANTRINE
	Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100726	Capsule	Fynale Forte SG 80/480 Capsule CAP 80 mg; 480 mg 1 X 6	79 NF-PP-331707 Fynale Forte SG 80/480 Capsule Soft Gel of Artemether and Lumefantrine Artemether 80mg Lumefantrine 480mg excipients q.s A4-100726 Drugs Imported Products 16 Over The Counter (OTC) 7/24/2023 AQUATIX PHARMACEUTICALS LIMITED, 14, PRINCE BODE OLUWO ST MENDE, MARYLAND LAGOS 7064946450 aquatixnigeria@gmail.com M/S.ASOJ SOFT CAPS PVT.LTD., PLOT no: 517 & 518, VILLAGE Asoj, BARODA-HALOL HIGHWAY, DIST: BARODA, 391510 GUJARAT INDIA, India	31/01/2024
A4-9924	Tablet	Fynale Tablets TAB 20 mg; 120 mg 3 x 8's	Tablet	28/01/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF01	Artemether and lumefantrine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100726, A4-9924